Sajjad Ullah Mphil: The Impact of Pharmacist-Led Anticoagulation Care in VTE
Sajjad Ullah Mphil, Pharmacist at Shaukat Khanum Memorial Cancer Hospital and Research Centre, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I am happy to share that our article has been published, offering valuable insights into ‘Pharmacist-led anticoagulation care in cancer: Associations with bleeding and VTE recurrence.’
Cancer patients are at a significantly higher risk of both thrombosis and bleeding, making anticoagulation management particularly complex.
This study was conducted to explore the impact of pharmacist-led anticoagulation care, focusing on its role in optimizing therapy, minimizing bleeding risks, and reducing the recurrence of venous thromboembolism (VTE).
Our findings add to the growing evidence supporting the clinical value of pharmacist involvement in multidisciplinary cancer care.
This landmark reflects dedication, enthusiasm, and strong leadership support.
I would like to express my sincere gratitude to Sir Omar Akhlaq Bhutta and my supervisor, Dr. Inayat Ur Rehman, for their constant guidance and unwavering support throughout this journey.
I am also deeply thankful to my co-author Dr. Javeria Khalid for her persistent support during challenging times.
Special appreciation to Dr. Yasir Shah and Prof. Long Ming for their continuous encouragement, patience, and motivation toward progress.
This will contribute to improving patient care and advancing the role of pharmacists in clinical practice.”
Title: Pharmacist-led anticoagulation care in cancer: Associations with bleeding and VTE recurrence
Authors: Sajjad Ullah, Inayat Ur Rehman, Javeria Khalid, Yasar Shah, Omar Akhlaq Bhutta, Long Chiau Ming
Read the Full Article on Journal of Oncology Pharmacy Practice
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 6, 2026, 19:25Ambreen Kashif: Highlighting the Impact of Temporary Donor Deferrals on Donor Retention
-
Jul 6, 2026, 19:23Rob Mac Sweeney: Anticoagulation Strategies for Cardiopulmonary Bypass in Heparin-Induced Thrombocytopenia
-
Jul 6, 2026, 19:22Nthabiseng Bapela: Interpreting INR in Patients on Warfarin – A Practical Clinical Framework
-
Jul 6, 2026, 19:20Hamza Mohamed: Key Highlights from the 2026 AHA/ACC Multisociety Guideline on Acute PE
-
Jul 6, 2026, 18:58Mostafa Faisal: High PNH Type II Neutrophil Proportions Are Associated With Thrombosis
-
Jul 6, 2026, 17:57When Hematocrit Exceeds 70 Percent: Challenges in Peripheral Blood Smear Evaluation and CBC Analysis – Seema Dawood
-
Jul 6, 2026, 17:382026 ACC/AHA Multisociety Dyslipidemia Guideline: Key Updates for Vascular Specialists – Batool Abuhalimeh
-
Jul 6, 2026, 17:27Nicolas Gendron: Should Carbon Footprint Influence Therapeutic Decisions?
-
Jul 6, 2026, 17:15Sanchit Sharma։ Continuous Anticoagulation in PVT with Varices